LifeView In The News

Polygenic risk scores enable patients and their IVF providers to prioritize embryo transfers with greater precision. Our Embryo Health Score Test is at the forefront of this revolutionary approach, providing deeper genomic insights that refine embryo selection.

The Cassidys’ doctor told them about a company that could assess their potential children’s odds of developing conditions that aren’t tied to a single gene. All the company needed was an embryo biopsy.

A New Jersey company says its test can screen embryos for a variety of diseases and health conditions, like heart disease, diabetes, or breast cancer.
More
Other Recent Media...
- Inherent Biosciences, Genomic Prediction Announce Partnership
- LifeView PGT Now New York State Licensed
- Genomic Prediction Promotes Kelly Ketterson to Chief Executive Officer
- Ovation Fertility Licenses Genomic Prediction's LifeView PGT
- Genomic Prediction Technology Uncovers New CRISPR Safety Concerns in Human Embryos
